One of the main fears regarding new SARS-CoV-2 variants is that they might be resistant to immunity granted by vaccines, including RNA vaccines.
Articles on Coronavirus South Africa variant
Displaying all articles
What does the Seychelles experience tell us about variants, vaccine efficacy and herd immunity?
Variants of the original SARS-CoV-2 are now in wide circulation. That means the third wave of COVID-19 has come with new questions about the variants, their effects and what might come next.
COVID-19 variants of concern have changed the game. We need to recognise and act on this to avoid future waves of infections, yet more lockdowns and restrictions, and avoidable illness and death.
We can help vaccines keep up with the mutating coronavirus by doubling down on preventive measures.
Top contributors
-
Médecin, Professeure des Universités – Praticienne Hospitalière, Université de Lille
-
Assistant Professor of Global Health and Microbiological Sciences, Executive Director - Center for Sustainable Development (Earth Institute), Columbia University
-
Professor of Public Health, University of Auckland, Waipapa Taumata Rau
-
Associate Professor in Viral Immunology, University of Birmingham
-
John Thwaites is a Friend of The Conversation.
Chair, Monash Sustainable Development Institute & ClimateWorks Australia, Monash University
-
Director, Centre for the AIDS Program of Research in South Africa (CAPRISA)
-
Associate Research Professor, Barcelona Institute for Global Health (ISGlobal)
-
Professor and Canada Research Chair in Evidence-Support Systems, McMaster University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW
-
Professor of Health Psychology and Director of the UCL Centre for Behaviour Change, UCL
-
Director, BehaviourWorks, Monash Sustainable Development Institute, Monash University
-
Digital and Communications Manager
-
Professor, Biology, York University, Canada